Home › FDA Approves Blood Cancer Drug
 

Keywords :   


FDA Approves Blood Cancer Drug

2015-12-01 00:27:14| Biotech - Topix.net

The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. The FDA said it approved the treatment, Empliciti, to be used in multiple myeloma patients in combination with Celgene Corp's Revlimid and common anti-inflammatory drug dexamethasone.

Tags: blood drug cancer fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05Derrell Peel: So far so good, but be cautious of 2024 pasture and hay conditions
21.05Derrell Peel: So far so good, but be cautious of 2024 pasture and hay conditions
21.05Stanford, Colo. State lead review of fire research
21.05Atlantic Tropical Weather Outlook
21.05Eastern North Pacific Tropical Weather Outlook
21.05BMW and Jaguar used banned China parts - US probe
21.05Government will use unemployed bootcamps to fill job gaps, says Stride
21.05The AI tech helping stop Indian elephant accidents
More »